NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medical University in Osaka, Japan. Under the guidance of Dr. Toshio Shimizu as the Director of the Phase I program, Kansai Medical University will now offer patients in Japan the opportunity to participa…
Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi, a global leader in AI drug discovery, announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and development of bispecific antibodies for the treatment of various diseases.…
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND", announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR-T cells. This agreement represents…
Insurance leader Vitality and Google today announced a global partnership to launch Vitality AI. This new platform will integrate Google Cloud's advanced AI and data analytics, with Vitality's vast health datasets and behavior-change expertise, to transform how millions worldwide understand and manage their health. Th…
Singapore-based Raffles Medical Group and Gene Solutions, headquartered in Vietnam, have signed a Memorandum of Understanding (MoU) to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia. Under this partnership, the Raffles Med…
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and Shanghai ZJ Bio-Tech technology Co., Ltd. jointly announced the official signing of a strategic cooperation agreement on the automated development of innovative biologics. This collaboration aims to jointly tackle drug development bottlenecks by introducing automation…
Novartis announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. With the completion of the acquisition, shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline, have ceased trading on the Nasdaq Stock Market LLC and Tourmaline is now an indirect wholly owned subs…
Bristol Myers Squibb and Orbital Therapeutics announced a definitive agreement under which BMS will acquire Orbital, a privately held biotechnology company pioneering a new generation of RNA medicines that reprogram the immune system in vivo, enabling treatments that provide the precision, control, and flexibility nee…
LOTTE BIOLOGICS and SK pharmteco announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market. Through this collaboration, the two companies will jointly investigate providing integrated, one-stop CDMO ser…
Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function. The collaboration leverages Chromatin Bio's proprietary synthetic promoter design…
Page 26 of 39